文章:
SWI/SNF核小体重塑剂与癌症
SWI/SNF nucleosome remodellers and cancer
原文发布日期:2011-06-09
DOI: 10.1038/nrc3068
类型: Review Article
开放获取: 否
要点:
- Specific inactivating mutations in subunits of SWI/SNF chromatin remodelling complexes, including the SNF5 (also known as SMARCB1, INI1 and BAF47), ARID1A (also known as BAF250A and SMARCF1), BAF180 (also known as PBRM1) and BRM/SWI2-related gene 1 (BRG1; also known as SMARCA4) subunits, occur at a high frequency in several types of cancer.
- Genetically engineered mice carrying mutations in Snf5 and Brg1 have established that at least some SWI/SNF subunits have bona fide tumour suppressor activity.
- SWI/SNF complexes regulate gene expression by using the energy of ATP to remodel chromatin.
- A central function of SWI/SNF complexes is the coordinated regulation of gene expression programmes. These complexes have essential roles during lineage specification and in the maintenance of stem cell pluripotency.
- Emerging evidence has identified key pathways that contribute to tumorigenesis following perturbation of SWI/SNF complexes.
- Collectively, enzymes that modify chromatin structure are emerging as key regulators of tumorigenesis. As epigenetic alterations are potentially reversible, unlike DNA mutations, the targeted inhibition of chromatin-modifying enzymes may have important therapeutic implications for cancer.
要点翻译:
- SWI/SNF染色质重塑复合物的特定亚基失活突变在多种癌症中高频发生,这些亚基包括SNF5(亦称SMARCB1、INI1和BAF47)、ARID1A(亦称BAF250A和SMARCF1)、BAF180(亦称PBRM1)以及BRM/SWI2相关基因1(BRG1;亦称SMARCA4)。
- 携带Snf5和Brg1基因突变的基因工程小鼠模型证实,至少部分SWI/SNF亚基具有确切的肿瘤抑制活性。
- SWI/SNF复合物通过利用ATP能量重塑染色质来调控基因表达。
- 该复合物的核心功能是协调基因表达程序的调控,在细胞谱系分化和维持干细胞多能性过程中发挥关键作用。
- 最新证据揭示了SWI/SNF复合物功能紊乱后促进肿瘤发生的关键通路。
- 总体而言,修饰染色质结构的酶类正逐渐被视为肿瘤发生的关键调控因子。表观遗传改变具有可逆性潜能(不同于DNA突变),因此靶向抑制染色质修饰酶可能为癌症治疗带来重要突破。
英文摘要:
SWI/SNF chromatin remodelling complexes use the energy of ATP hydrolysis to remodel nucleosomes and to modulate transcription. Growing evidence indicates that these complexes have a widespread role in tumour suppression, as inactivating mutations in several SWI/SNF subunits have recently been identified at a high frequency in a variety of cancers. However, the mechanisms by which mutations in these complexes drive tumorigenesis are unclear. In this Review we discuss the contributions of SWI/SNF mutations to cancer formation, examine their normal functions and discuss opportunities for novel therapeutic interventions for SWI/SNF-mutant cancers.
摘要翻译:
SWI/SNF染色质重塑复合物利用ATP水解的能量重塑核小体并调节转录。越来越多的证据表明,这些复合物在肿瘤抑制中具有广泛作用,因为最近在多种癌症中以高频率发现了几个SWI/SNF亚基的失活突变。然而,这些复合物突变驱动肿瘤发生的机制尚不清楚。在本综述中,我们讨论了SWI/SNF突变对癌症形成的贡献,审视了它们的正常功能,并探讨了针对SWI/SNF突变癌症的新型治疗干预措施的机会。
原文链接:
SWI/SNF nucleosome remodellers and cancer